Estefania Labanca

10PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 15, 2026
HO-1 Nuclear Interactome Implications in Neuroendocrine Transdifferentiation in Prostate Cancer.

|Aug 02, 2025
PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression.

Pablo Sanchis, Agustina Sabater, Julia Lechuga

|Apr 22, 2024
Kinesin Facilitates Phenotypic Targeting of Therapeutic Resistance in Advanced Prostate Cancer.

Maddison Archer, Diane Begemann, Edgar Gonzalez-Kozlova

|Mar 15, 2024
Integrative Molecular Analyses of the MD Anderson Prostate Cancer Patient-derived Xenograft (MDA PCa PDX) Series.

Nicolas Anselmino, Estefania Labanca, Peter D A Shepherd

|May 14, 2022
Bone Progenitors Pull the Strings on the Early Metabolic Rewiring Occurring in Prostate Cancer Cells.

Pablo Sanchis, Nicolas Anselmino, Sofia Lage-Vickers

|Feb 25, 2022
Exploiting Interdata Relationships in Prostate Cancer Proteomes: Clinical Significance of HO-1 Interactors.

Sofia Lage-Vickers, Pablo Sanchis, Juan Bizzotto

Pageof 2

Frequent Collaborators

8 joint publications

Elba Vazquez

6 joint publications

Javier Cotignola

6 joint publications

Geraldine Gueron

5 joint publications

Nora Navone